Background: The t:slim X2™ insulin pump with Control-IQ^® technology from Tandem Diabetes Care is an advanced hybrid closed-loop system that was first commercialized in the United States in January 2020. Longitudinal glycemic outcomes associated with real-world use of this system have yet to be reported.

中文翻译：

---

Control-IQ 高级混合闭环技术实际使用一年

背景： ^{Tandem Diabetes Care 采用 Control-IQ ®}技术的 t:slim X2™ 胰岛素泵是一种先进的混合闭环系统，于 2020 年 1 月在美国首次商业化。与现实世界使用相关的纵向血糖结果该系统尚未报告。